Since it is reported in literature that the leptin effects are mediated by MAPK signaling pathway in thyroid cancer [11], here we evaluated whether the pharmacological inhibition of BRAF impairs the combined effects of the two adipokines on thyroid cancer cell proliferation. This evidence concerns the gene BRAF and thyroid gland carcinoma.